Display options
Cite
Elpek GO. Orosomucoid in liver diseases. World J Gastroenterol. 2021;27(45):7739-7747doi: 10.3748/wjg.v27.i45.7739.
Elpek, G. O. (2021). Orosomucoid in liver diseases. World journal of gastroenterology, 27(45), 7739-7747. https://doi.org/10.3748/wjg.v27.i45.7739
Elpek, Gulsum Ozlem. "Orosomucoid in liver diseases." World journal of gastroenterology vol. 27,45 (2021): 7739-7747. doi: https://doi.org/10.3748/wjg.v27.i45.7739
Elpek GO. Orosomucoid in liver diseases. World J Gastroenterol. 2021 Dec 07;27(45):7739-7747. doi: 10.3748/wjg.v27.i45.7739. PMID: 34963738; PMCID: PMC8661375.
Copy Download .nbib Format: NLM
Share it on

World J Gastroenterol. 2021 Dec 07;27(45):7739-7747. doi: 10.3748/wjg.v27.i45.7739.

Orosomucoid in liver diseases.

World journal of gastroenterology

Gulsum Ozlem Elpek

Affiliations

  1. Department of Pathology, Akdeniz University Medical School, Antalya 07070, Turkey. [email protected].

PMID: 34963738 PMCID: PMC8661375 DOI: 10.3748/wjg.v27.i45.7739

Abstract

In this editorial, the roles of orosomucoid (ORM) in the diagnoses and follow-up assessments of both nonneoplastic diseases and liver tumors are discussed with respect to the publication by Zhu

©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Keywords: Alpha-1-acid glycoprotein; Downregulation; Hepatocellular carcinoma; Orosomucoid; Viral hepatitis; cirrhosis

Conflict of interest statement

Conflict-of-interest statement: There is not any conflict of interest.

Publication Types